{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:56:44Z","timestamp":1790751404096,"version":"4.1.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tertiary lymphoid structures (TLSs) are ectopic immune aggregates that arise in non-lymphoid tissues during chronic inflammation, including cancer. Their reported associations with antitumor immunity and immune-checkpoint blockade have prompted rapid growth of the field. We therefore mapped the literature on TLSs in cancer immunotherapy over the prespecified period from January 1, 2000 through March 31, 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The primary bibliometric corpus comprised 1,373 English-language articles and reviews from the Web of Science Core Collection (WoSCC). PubMed and Scopus were searched independently for descriptive comparison and were not merged with the WoSCC corpus. Analyses used bibliometrix, VOSviewer, CiteSpace, SCImago Graphica, and Microsoft Excel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Publication output rose markedly after 2019 and reached 315 publications in 2025. China, the United States, and France were the leading corresponding-author countries\/regions, while INSERM, Sun Yat-sen University, and Fudan University led the distinct-document institutional count. Major mapped themes included B cells, immune-checkpoint blockade, spatial pathology, prognostic modeling, the tumor microenvironment, lymphatic vessels, and high endothelial venules. The independently retrieved PubMed and Scopus datasets showed broadly similar aggregate temporal and title\/abstract term profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The analysis describes the growth, collaboration structure, and thematic development of TLS research in cancer immunotherapy. These bibliometric patterns indicate research attention; they do not establish biological mechanisms, biomarker performance, therapeutic efficacy, or clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1907300","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:57Z","timestamp":1790748417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global trends and knowledge evolution of tertiary lymphoid structures in cancer immunotherapy: a bibliometric and visualization analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Bio-therapeutic, The First Medical Centre, Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Bio-therapeutic, The First Medical Centre, Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Bio-therapeutic, The First Medical Centre, Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Bio-therapeutic, The First Medical Centre, Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Bio-therapeutic, The First Medical Centre, Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]},{"name":"Changping Laboratory","place":["Beijing, China"]},{"name":"National Clinical Research Centre for Hematologic Diseases, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Bio-therapeutic, The First Medical Centre, Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1352805","article-title":"Adoptive T cell therapy for solid tumors: current landscape and future challenges","volume":"15","author":"Albarr\u00e1n","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1146738","article-title":"The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","article-title":"Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer","volume":"15","author":"Kasikova","year":"2024","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.10.022","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy","volume":"166","author":"Hu","year":"2024","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03310-5","article-title":"Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02235-9","article-title":"Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors","volume":"128","author":"Hayashi","year":"2023","journal-title":"Br J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","article-title":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","volume":"42","author":"MacFawn","year":"2024","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0991","article-title":"Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma","volume":"15","author":"Hugaboom","year":"2025","journal-title":"Cancer Discov"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1296511","article-title":"Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023","volume":"13","author":"Lian","year":"2024","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1210802","article-title":"Bibliometric study of immunotherapy for hepatocellular carcinoma","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: An intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1396808","article-title":"The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2025.12.011","article-title":"B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity","volume":"44","author":"Chen","year":"2026","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147480","article-title":"Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry","volume":"14","author":"Le Rochais","year":"2023","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216513","article-title":"Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma","volume":"581","author":"Gan","year":"2024","journal-title":"Cancer Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00421-7","article-title":"Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors","volume":"4","author":"van Rijthoven","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003353","article-title":"High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer","volume":"9","author":"Park","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16468","DOI":"10.1038\/s41598-023-43122-w","article-title":"High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC","volume":"13","author":"Ye","year":"2023","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","article-title":"Tertiary lymphoid structures critical for prognosis in endometrial cancer patients","volume":"13","author":"Horeweg","year":"2022","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1074","article-title":"The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma","volume":"12","author":"Ling","year":"2022","journal-title":"Clin Transl Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41698-024-00533-w","article-title":"Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","article-title":"Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409560122","article-title":"Chemokine\/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity","volume":"122","author":"Falahat","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41541-024-01055-z","article-title":"TLR7\/8\/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity","volume":"10","author":"Wu","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202508095","article-title":"CXCL13 expression promotes CAR T cell antitumor activity and potentiates response to PD-1 blockade","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-022-04486-4","article-title":"Why do papers from international collaborations get more citations? A bibliometric analysis of library and information science papers","volume":"127","author":"Velez-Estevez","year":"2022","journal-title":"Scientometrics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc For Inf Sci Technol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001834","article-title":"Digital assessment of tertiary lymphoid structures and therapeutic responses in gastric cancer: a multicentric retrospective study","volume":"110","author":"Chen","year":"2024","journal-title":"Int J Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1038\/s41467-024-53262-w","article-title":"Spatial dynamics of CD39(+)CD8(+) exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer","volume":"15","author":"Tanoue","year":"2024","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000002599","article-title":"The effectiveness of whole lung lavage in pneumoconiosis: a systematic review and meta-analysis","volume":"64","author":"Zeng","year":"2022","journal-title":"J Occup Environ Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1475062","article-title":"Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023","volume":"15","author":"Bao","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1907300\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:58Z","timestamp":1790748418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1907300\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2026.1907300"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1907300","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1907300"}}